Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
9.33
+0.12 (1.30%)
Apr 23, 2025, 4:00 PM EDT - Market closed

Anavex Life Sciences Market Cap

Anavex Life Sciences has a market cap or net worth of $793.65 million as of April 23, 2025. Its market cap has increased by 118.70% in one year.

Market Cap
793.65M
Enterprise Value
671.17M
1-Year Change
118.70%
Ranking
Category
Stock Price
$9.33

Market Cap Chart

Since January 25, 2007, Anavex Life Sciences's market cap has increased from $59.50M to $793.65M, an increase of 1,233.86%. That is a compound annual growth rate of 15.25%.

History

DateMarket Cap% Change
Apr 22, 2025783.40M-14.00%
Dec 31, 2024910.90M19.20%
Dec 29, 2023764.20M5.86%
Dec 30, 2022721.90M-45.24%
Dec 31, 20211.32B264.55%
Dec 31, 2020361.60M148.69%
Dec 31, 2019145.40M100.00%
Dec 31, 201872.70M-48.95%
Dec 29, 2017142.40M-9.24%
Dec 30, 2016156.90M-18.58%
Dec 31, 2015192.70M1,752.88%
Dec 31, 201410.40M11.83%
Dec 31, 20139.30M-61.09%
Dec 31, 201223.90M-28.01%
Dec 30, 201133.20M-63.79%
Dec 31, 201091.70M102.88%
Dec 31, 200945.20M-12.23%
Dec 31, 200851.50M-48.91%
Dec 31, 2007100.80M69.41%
View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 744.65B
UnitedHealth Group 389.54B
Johnson & Johnson 374.10B
AbbVie 313.02B
Novo Nordisk 276.62B
Abbott Laboratories 225.15B
AstraZeneca 213.42B
Novartis AG 208.99B
Market Cap Rankings